At first glance, it may seem straightforward to assume that an inclusion complex formed between a GRAS-listed guest molecule and a GRAS-listed host, such as γ-cyclodextrin, would also qualify as GRAS. From a regulatory perspective, however, this is not always the case. Complex formation can alter the physicochemical properties of the guest compound, potentially affecting its stability, solubility, absorption kinetics, and bioavailability. In some cases, γ-cyclodextrin may increase the rate or extent of absorption of the encapsulated ingredient, leading to exposure levels that differ from those of the uncomplexed substance. Consequently, the safety of the inclusion complex must be evaluated based on its intended use and anticipated dietary exposure rather than inferred solely from the GRAS status of its individual components.
The U.S. Food and Drug Administration (FDA) has recently issued a favorable response to GRAS Notice No. 1292, concluding that it has no questions regarding HealthTech Bio Actives’ determination that a novel citrus-derived sweetener composed of neohesperidin dihydrochalcone (NHDC) and γ-cyclodextrin (γ-CD) is Generally Recognized as Safe (GRAS) for its intended food uses.
A New Application of γ-Cyclodextrin
The ingredient consists of an approximately 30:70 inclusion complex of NHDC and γ-cyclodextrin, produced by dissolving both components in water followed by spray drying. Rather than introducing a new sweetening molecule, the formulation leverages γ-cyclodextrin’s ability to form molecular inclusion complexes, improving the handling and functionality of NHDC, a high-intensity sweetener derived from citrus flavonoids. More information: https://htba.com/citrose/
Intended Food Applications
The FDA response covers the use of the complex across a broad range of foods, including:
- Soft drinks and fruit beverages
- Yogurts and flavored milk
- Cakes, cookies, pastries, and confectionery
- Nutrition and sports drinks
- Sugar substitutes
- Soups and other processed foods
The intended use excludes infant formula and products regulated by the U.S. Department of Agriculture. Maximum use levels range from 33.3 mg/kg in beverages to 3,333 mg/kg in tabletop sugar substitutes.
Why Is This Significant?
This FDA response highlights commercial application of γ-cyclodextrin as a functional food ingredient, extending its role beyond stabilization into the development of innovative sweetener systems.
HealthTech’s safety assessment relied on the well-established safety profiles of both NHDC and γ-cyclodextrin, including previous FDA GRAS notices for each individual component (GRN 902 for NHDC and GRN 46 for γ-CD). The company also presented manufacturing data, product specifications, dietary exposure estimates, and toxicological evidence demonstrating that the complex dissociates after ingestion into its two familiar constituents.
FDA’s Conclusion
As is customary for GRAS notifications, the FDA did not “approve” the ingredient. Instead, the Agency stated that, based on the information submitted and other available data, it has no questions regarding the notifier’s conclusion that the citrus-derived NHDC/γ-cyclodextrin complex is GRAS under the proposed conditions of use. The FDA also noted that manufacturers remain responsible for ensuring compliance with all applicable food safety and labeling regulations.
Growing Opportunities for Cyclodextrins
This decision further demonstrates the expanding role of cyclodextrins in food innovation. While β-cyclodextrin has traditionally dominated food applications, γ-cyclodextrin continues to gain attention as a versatile ingredient capable of enhancing the performance of flavors, bioactives, and now high-intensity sweeteners. The latest FDA response adds another example to the growing portfolio of commercially relevant cyclodextrin-enabled technologies and illustrates how molecular encapsulation can create value without introducing new chemical entities.
Source: https://www.hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=grasnotices&id=1292
Image: A. Barra, CC BY-SA 4.0, via Wikimedia Commons
